PT2024748E - Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata - Google Patents

Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata

Info

Publication number
PT2024748E
PT2024748E PT77259497T PT07725949T PT2024748E PT 2024748 E PT2024748 E PT 2024748E PT 77259497 T PT77259497 T PT 77259497T PT 07725949 T PT07725949 T PT 07725949T PT 2024748 E PT2024748 E PT 2024748E
Authority
PT
Portugal
Prior art keywords
anexin
monoclonal antibodies
prostate carcinoma
carcinoma detection
detection
Prior art date
Application number
PT77259497T
Other languages
English (en)
Portuguese (pt)
Inventor
Andre Schrattenholz
Original Assignee
Proteosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteosys Ag filed Critical Proteosys Ag
Publication of PT2024748E publication Critical patent/PT2024748E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT77259497T 2006-06-09 2007-06-11 Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata PT2024748E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US85948906P 2006-11-17 2006-11-17

Publications (1)

Publication Number Publication Date
PT2024748E true PT2024748E (pt) 2013-01-16

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77259497T PT2024748E (pt) 2006-06-09 2007-06-11 Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata

Country Status (13)

Country Link
US (1) US8012697B2 (OSRAM)
EP (1) EP2024748B1 (OSRAM)
JP (1) JP2009540278A (OSRAM)
KR (1) KR20090023372A (OSRAM)
AU (1) AU2007256377B2 (OSRAM)
CA (1) CA2654330A1 (OSRAM)
DE (1) DE07725949T1 (OSRAM)
DK (1) DK2024748T3 (OSRAM)
ES (1) ES2396730T3 (OSRAM)
PL (1) PL2024748T3 (OSRAM)
PT (1) PT2024748E (OSRAM)
RU (1) RU2467335C2 (OSRAM)
WO (1) WO2007141043A2 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
CA2738032A1 (en) * 2008-09-26 2010-04-01 Proteosys Ag Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) * 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
US9487831B2 (en) * 2013-09-12 2016-11-08 Versitech Limited Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
US20030108963A1 (en) 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
EP1724586A3 (en) 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
AU2007256377A1 (en) 2007-12-13
WO2007141043A2 (en) 2007-12-13
US20100233160A1 (en) 2010-09-16
JP2009540278A (ja) 2009-11-19
DK2024748T3 (da) 2013-03-18
EP2024748B1 (en) 2012-12-12
AU2007256377B2 (en) 2012-11-01
WO2007141043A3 (en) 2008-03-20
PL2024748T3 (pl) 2013-05-31
RU2467335C2 (ru) 2012-11-20
ES2396730T3 (es) 2013-02-25
CA2654330A1 (en) 2007-12-13
EP2024748A2 (en) 2009-02-18
RU2008152009A (ru) 2010-07-20
KR20090023372A (ko) 2009-03-04
US8012697B2 (en) 2011-09-06
DE07725949T1 (de) 2009-07-02

Similar Documents

Publication Publication Date Title
LT3421498T (lt) Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui
NO344963B1 (no) Humanisert antistoff
IL196470A (en) Antagonist antibody for the treatment of cancer
EP2121751A4 (en) MONOCLONAL ANTIBODIES AGAINST ANGPTL3
DK2019840T3 (da) Antagonist anti-human CD40 monoklonalt antistof.
PL2178921T3 (pl) Monoklonalne przeciwciała przeciwko glipikanowi-3
IL197217B (en) Novel anti-cd38 antibodies for the treatment of cancer
EP2021373A4 (en) MONOCLONAL ANTIBODY VCAM-1 SPECIFIC
CR10705A (es) Anticuerpos para linfotoxina-alfa
ZA201000049B (en) Monoclonal antibeta amyloid antibody
EP2324359A4 (en) MONOCLONAL ANTIBODY STRO-4
DK2115472T3 (da) Cancerbiomarkører
BRPI0814111A2 (pt) Anticorpo monoclonal citotóxico anticâncer
BRPI0918178A2 (pt) anticorpos monoclonais para tratamento de câncer
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
FI20070853A0 (fi) Glykaania sitovat monoklonaaliset vasta-aineet
PT2207037T (pt) Método para a deteção de cancro
HRP20180485T1 (hr) Monoklonska antitijela za gt468 za liječenje raka
BRPI0817427A2 (pt) Anticorpo anti-bst2
BRPI0819765A2 (pt) Conjugados de anticorpos anti-rg-1
BRPI0715544A2 (pt) Anticorpos que modificam doença cancerosas.
BRPI0807858A2 (pt) Anticorpo de modificação de doença cancerosa
DK2094728T3 (da) Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer
PL2024748T3 (pl) Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego
BRPI0807861A2 (pt) Anticorpo de modificação de doença cancerosa